Skip to content

Maurizio Popoli

3 papers in the library · 190 citations · publishing 2016-2024

Papers

Sort Most recent Most cited

Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD.

Translational Psychiatry May 25, 2024 Marta Valenza, Roberta Facchinetti, Carola Torazza et al. 26 citations

Stress affects the brain and alters its neuroarchitecture and function; these changes can be severe and lead to psychiatric disorders. Recent evidence suggests that astrocytes and microglia play an essential role in the stress response by contributing to the maintenance of cerebral homeostasis. These cells respond rapidly to all stimuli that reach the brain, including stressors. Here, we used a...

DOI: 10.1038/s41398-024-02928-6 (opens in new tab) Full text (opens in new tab) Mental health Ketamine therapy Brain research Stress disorders

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments

The International Journal of Neuropsychopharmacology November 14, 2018 Bashkim Kadriu, Laura Musazzi, Ioline D. Henter et al. 164 citations

The underlying neurobiological basis of major depressive disorder remains elusive due to the severity, complexity, and heterogeneity of the disorder. While the traditional monoaminergic hypothesis has largely fallen short in its ability to provide a complete picture of major depressive disorder, emerging preclinical and clinical findings suggest that dysfunctional glutamatergic...

PS125. Functional and morphological changes induced by ketamine in the hippocampus

The International Journal of Neuropsychopharmacology May 27, 2016 G. Treccani, Liebenberg N. Nico, S. Tillmann et al.

Specific objective of the study: This study is aimed to investigate desipramine, venlafaxine and bupropion on depression and anxiety in mice. Methods used: We used a classic tricyclic antidepressant, desipramine; a serotonin-norepinephrine reuptake inhibitör, venlafaxine; a second-generation antidepressant agent that blocks centrally the reuptake of noradrenaline and dopamine, bupropion in...